Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 11 | Future Journal of Pharmaceutical Sciences

Fig. 11

From: Exploration of the aptitude to alleviate oxidative impairment and curb colorectal cancer manifestation by Nostoc calcicola in HT-29 adenocarcinoma cells

Fig. 11

GCMS profiling showing mass spectra with the structure of major compound in the Nostoc calcicola methanol extract a Hexadecanoic acid, (2-pentadecyl-1,3-dioxolan-4-yl)methyl ester, b 5-Amino-1-ethyl-1,2,3-triazole-4-carboxamide, c 1,2,3-thiadiazole, propanoic acid derivative and (d) 3,4-Dihydroxymandelic acid, ethyl ester, tri-TMS

Back to article page